Sharon D. Morgenbesser

3.3k total citations · 2 hit papers
16 papers, 2.8k citations indexed

About

Sharon D. Morgenbesser is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sharon D. Morgenbesser has authored 16 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Sharon D. Morgenbesser's work include Cancer-related Molecular Pathways (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Sharon D. Morgenbesser is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Neuroblastoma Research and Treatments (3 papers). Sharon D. Morgenbesser collaborates with scholars based in United States, Australia and France. Sharon D. Morgenbesser's co-authors include Ronald A. DePinho, Melanie H. Cobb, George D. Yancopoulos, David J. Robbins, Steven H. Nye, Teri G. Boulton, Nikos Panayotatos, Nancy Y. Ip, Tyler Jacks and Bart O. Williams and has published in prestigious journals such as Nature, Cell and Genes & Development.

In The Last Decade

Sharon D. Morgenbesser

16 papers receiving 2.7k citations

Hit Papers

ERKs: A family of protein-serine/threonine kinases that a... 1991 2026 2002 2014 1991 1994 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon D. Morgenbesser United States 14 2.2k 790 380 290 269 16 2.8k
Barbara Marte United States 19 2.3k 1.1× 767 1.0× 484 1.3× 204 0.7× 284 1.1× 36 3.0k
Andreas Marti Switzerland 20 2.0k 0.9× 797 1.0× 219 0.6× 291 1.0× 389 1.4× 30 2.8k
Christiane Susini France 40 1.7k 0.8× 1.4k 1.8× 257 0.7× 339 1.2× 209 0.8× 87 4.1k
Alan Wolfman United States 30 3.5k 1.6× 880 1.1× 659 1.7× 288 1.0× 377 1.4× 49 4.4k
Steven Swendeman United States 27 1.7k 0.8× 599 0.8× 283 0.7× 149 0.5× 267 1.0× 35 2.6k
Steven A. Reeves United States 27 2.0k 0.9× 683 0.9× 278 0.7× 844 2.9× 293 1.1× 37 3.1k
Curt M. Pfarr United States 16 1.9k 0.9× 472 0.6× 598 1.6× 370 1.3× 338 1.3× 24 2.4k
Michiko Shirane Japan 20 2.6k 1.2× 1.3k 1.6× 815 2.1× 215 0.7× 361 1.3× 32 3.5k
Anatoly Nikolaev United States 11 2.3k 1.0× 1.2k 1.5× 287 0.8× 230 0.8× 358 1.3× 15 3.5k
Sheldon Rowan United States 31 2.7k 1.3× 1.2k 1.5× 346 0.9× 220 0.8× 344 1.3× 57 3.6k

Countries citing papers authored by Sharon D. Morgenbesser

Since Specialization
Citations

This map shows the geographic impact of Sharon D. Morgenbesser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon D. Morgenbesser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon D. Morgenbesser more than expected).

Fields of papers citing papers by Sharon D. Morgenbesser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon D. Morgenbesser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon D. Morgenbesser. The network helps show where Sharon D. Morgenbesser may publish in the future.

Co-authorship network of co-authors of Sharon D. Morgenbesser

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon D. Morgenbesser. A scholar is included among the top collaborators of Sharon D. Morgenbesser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon D. Morgenbesser. Sharon D. Morgenbesser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bagley, Rebecca G., Cécile Rouleau, Sharon D. Morgenbesser, et al.. (2006). Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy. Microvascular Research. 71(3). 163–174. 30 indexed citations
2.
3.
Morgenbesser, Sharon D., Cécile Rouleau, Rebecca G. Bagley, et al.. (2004). Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells. Clinical Cancer Research. 10(6). 2179–2189. 54 indexed citations
4.
Cao, Xiaohong, William Weber, Sharon D. Morgenbesser, et al.. (2003). Identification of genes expressed in malignant cells that promote invasion.. PubMed. 63(24). 8939–47. 66 indexed citations
5.
Sood, Raman, Tom I. Bonner, Izabela Makałowska, et al.. (2001). Cloning and Characterization of 13 Novel Transcripts and the Human RGS8 Gene from the 1q25 Region Encompassing the Hereditary Prostate Cancer (HPC1) Locus. Genomics. 73(2). 211–222. 44 indexed citations
6.
Sood, Raman, Izabela Makałowska, John D. Carpten, et al.. (2000). The human RGL (RalGDS-like) gene: cloning, expression analysis and genomic organization. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1491(1-3). 285–288. 14 indexed citations
7.
Hatton, Kimi S., Kathleen Mahon, Lynda Chin, et al.. (1996). Expression and Activity of L-Myc in Normal Mouse Development. Molecular and Cellular Biology. 16(4). 1794–1804. 87 indexed citations
8.
Morgenbesser, Sharon D., Nicole Schreiber‐Agus, Miri Bidder, et al.. (1995). Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo.. The EMBO Journal. 14(4). 743–756. 51 indexed citations
9.
Morgenbesser, Sharon D. & Ronald A. DePinho. (1994). Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer.. PubMed. 5(1). 21–36. 59 indexed citations
10.
Morgenbesser, Sharon D., Bart O. Williams, Tyler Jacks, & Ronald A. DePinho. (1994). p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature. 371(6492). 72–74. 509 indexed citations breakdown →
11.
Williams, Bart O., Sharon D. Morgenbesser, Ronald A. DePinho, & Tyler Jacks. (1994). Tumorigenic and Developmental Effects of Combined Germ-line Mutations in Rb and p53. Cold Spring Harbor Symposia on Quantitative Biology. 59(0). 449–457. 8 indexed citations
12.
Torres, Richard, Nicole Schreiber‐Agus, Sharon D. Morgenbesser, & Ronald A. DePinho. (1992). Myc and Max: a putative transcriptional complex in search of a cellular target. Current Opinion in Cell Biology. 4(3). 468–474. 44 indexed citations
13.
Mukherjee, Bhramar, Sharon D. Morgenbesser, & Ronald A. DePinho. (1992). Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.. Genes & Development. 6(8). 1480–1492. 116 indexed citations
14.
Xu, Lin, Sharon D. Morgenbesser, & Ronald A. DePinho. (1991). Complex Transcriptional Regulation of myc Family Gene Expression in the Developing Mouse Brain and Liver. Molecular and Cellular Biology. 11(12). 6007–6015. 9 indexed citations
15.
Morgenbesser, Sharon D., et al.. (1991). Complex transcriptional regulation of myc family gene expression in the developing mouse brain and liver.. Molecular and Cellular Biology. 11(12). 6007–6015. 20 indexed citations
16.
Boulton, Teri G., Steven H. Nye, David J. Robbins, et al.. (1991). ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 65(4). 663–675. 1666 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026